New breast cancer drug copy tested in major trial
Disease control
Terminated
This study aimed to see if a new, similar version of the cancer drug pertuzumab (called PERT-IJS) works as well and is as safe as the original drug (EU-Perjeta) when given before surgery. It involved 55 women with a specific type of early or locally advanced breast cancer (HR-neg…
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Apr 02, 2026 10:57 UTC